A rising number of people have accepted GLP-1s as a way to treat obesity, which affects more than 100 million Americans.

A study confirmed that side effects like pancreatitis and kidney damage are possible while taking GLP-1s like Ozempic. Here's ...

Ozempic, the diabetes medication popularly used as an “off-label” weight-loss drug, has helped thousands shed excess pounds.

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a ...

The U.S. Centers for Medicare and Medicaid Services has named Novo Nordisk’s Wegovy, Ozempic and Rybelsus as part of the ...

News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...

Semaglutide, sold under the brand names of Ozempic, Rybelsus and Wegovy, is one of the most popular drugs on the market.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...

Could a diabetes and weight loss drug benefit the brain? Here’s what scientists are learning. By Dana G. Smith and Dani Blum Over a decade ago, a smattering of studies suggested that early ...

The use of injectable weight loss medications like Wegovy and Ozempic, both produced by Danish manufacturer Novo Nordisk, has grown massively in recent years, since the two drugs were approved for ...

Due to occasional supply chain issues, Ozempic may be difficult to get. In these cases, your healthcare professional may recommend an alternative, such as Wegovy, Zepbound, or Mounjaro.